West Virginia is making significant strides toward repealing its longstanding Certificate of Need (CON) law, a regulatory framework that mandates healthcare providers to obtain government approval before expanding services, opening new facilities, or purchasing major medical equipment. Governor
Texas, known for its fierce independence and minimal government interference, faces a paradox when it comes to healthcare regulation. Despite the state's reputation, it stands as the fifth-most-regulated state in the nation, a status that significantly impacts its economic growth, cost
The Australian cosmetic industry is experiencing rapid growth, with a market value of approximately $1.5 billion. This surge is fueled by increasing acceptance of cosmetic procedures and a growing number of clinics offering these services. However, this expansion brings to light the urgent need for
Recent developments in the field of healthcare have brought to light the multifaceted benefits of GLP-1 drugs, traditionally prescribed for diabetes and weight loss. Novo Nordisk's drug Ozempic (semaglutide) has shown potential in reducing alcohol consumption among individuals with alcohol-use
A recent study conducted by the Yale School of Medicine, published in the JAMA Health Forum, highlights serious concerns surrounding online advertising practices for compounded versions of GLP-1 receptor agonists (GLP-1 RAs) used to treat type 2 diabetes and for weight loss. These concerns are
New York is poised to expand its regulations governing significant healthcare transactions under the proposed Fiscal Year (FY) 2026 Executive Budget, unveiled by Governor Kathy Hochul on January 21, 2025. This budget proposes amendments to Article 45-A of New York’s Public Health Law, known as the D
